USD/CAD remains rangebound, stalling at 1.40 resistance and the 50-day EMA, with the pair consolidating between 1.39 and 1.41 amid cross-border trade noise and dollar volatility.

Biotech stocks offer exciting investment opportunities, but they carry greater risk than traditional pharmaceutical stocks. Learn about the best biotech stocks to buy now!

Two promising developments, expanding profit margins and increased earnings-per-share guidance for 2025, drive a bullish narrative. Can the post-earnings rally in Labcorp continue?

A massive 30%+ correction overshadows AI adoption, strong operational metrics, and a healthy dividend yield. Did the sell-off create a buy signal in Paychex?

One spin-off complete, two more to come in 2026, with high earnings-per-share expectations, and 25%+ upside potential. Time to go long oh Honeywell?

It is significant that key support levels continue to hold firm.